Early trials of the drug VIR-5500 showed it shrinking tumours in some patients ...

The American Cancer Society reports that about one in eight men will be diagnosed with prostate cancer in their lifetime. The ...

In recent decades, there have been enormous developments in cancer treatment. In the past, most patients received chemotherapy, a broad treatment that also damages healthy cells, but for several years ...

A drug for advanced prostate cancer has shown “remarkable” results in an early-stage trial, with patients who had previously stopped being receptive to treatment finding their tumours shrinking, ...

Imperial College London investigators compared focal therapy with prostate removal surgery for men with prostate cancer that ...

Vipul R. Patel, MD, FACS, is a board-certified urologic surgeon, medical director of the Global Robotics Institute at AdventHealth, and medical director of urologic oncology at AdventHealth Cancer ...

Multidisciplinary care in prostate cancer involves urologic, radiation, and medical oncologists, optimizing treatment through a collaborative approach. Clinical trials may benefit patients with ...

Prostate cancer that has spread to other parts of the body has limited treatment options, but a biomedical research group affiliated with Main Line Health has begun investigating a new therapy for ...

Significantly less progression, especially unstable lesions, with relugolix versus leuprol ...

A new drug for advanced prostate cancer has shown promise in early trials experts have said, with the medication shrinking tumors in some patients. Prostate cancer is the most common cancer among men ...